Birth prevalence of congenital heart disease worldwide: a systematic review and meta-analysis.
Denise van der Linde, Elisabeth E M Konings, Maarten A Slager...
https://pubmed.ncbi.nlm.nih.gov/22078432/Actively Recruiting
Led by University Hospital, Basel, Switzerland · Updated on 2026-05-04
5000
Participants Needed
6
Research Sites
N/A
Total Duration
Researchers are collecting detailed health information about adults who were born with congenital heart disease and are being treated in specialized centers in Switzerland. This registry study aims to better understand long-term complications and treatment outcomes for this growing population, as advances in pediatric heart care have allowed most children with congenital heart defects to reach adulthood. The study is observational and focuses on gathering data rather than testing treatments. Participants in this study will have their medical data, including diagnoses, previous treatments, and any cardiac complications, recorded after each visit to a participating center. The information is entered securely into a web-based database to create a nationwide registry. This registry will help provide a clearer picture of the adult congenital heart disease population in Switzerland and improve knowledge about their long-term health outcomes. During the study, participants health status will be monitored annually for up to 20 years, with a focus on tracking cardiac complications and mortality. The study involves routine clinical visits where data is collected based on patients ongoing care. The registry helps researchers understand the health trends and risks in this group over time without altering usual medical care.
CONDITIONS
Swiss National Registry of Adults With Congenital Heart Disease
D
Daniel Tobler, MD
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here
University Hospital, Basel, Switzerland
Lead Sponsor
You may qualify if you...
You will not qualify if you...
Duration - 2 to 4 weeks
Participants are screened for eligibility to participate in the trial.
1 visit (in-person)
Duration - Up to 20 years
Participants who undergo routine care are observed to collect long-term health data including cardiac complications and mortality.
Annual visits for up to 20 years
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Have more questions? Get in touch with our team for quick support
Denise van der Linde, Elisabeth E M Konings, Maarten A Slager...
https://pubmed.ncbi.nlm.nih.gov/22078432/Philip Moons, Lore Bovijn, Werner Budts...
https://pubmed.ncbi.nlm.nih.gov/21098444/Ketina Arslani, Nico Roffler, Marzena Zurek...
https://pubmed.ncbi.nlm.nih.gov/30527151/Julien I E Hoffman, Samuel Kaplan
https://pubmed.ncbi.nlm.nih.gov/12084585/University Hospital, Basel, Switzerland
Lead Sponsor